var data={"title":"Society guideline links: Obsessive-compulsive disorder and related disorders","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Society guideline links: Obsessive-compulsive disorder and related disorders</div><p class=\"disclosureLink\"></p><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1964995806\"><span class=\"h1\">Introduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.</p><p>The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.</p><p class=\"headingAnchor\" id=\"H2621871683\"><span class=\"h1\">International</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Bandelow_et_al_01.pdf&amp;token=FABGhCIW+qDHQvW/Th4seuOEnL468+0D7Bi6DtUDlEEt7yd7a1NwihTfE/jXO/bIcVBjpZDuuSVb5W5fYIHfP6aNmBRLsI4yQV+Pbw/vIhaKK3eQgVKxjMy8XiFeKNKv&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Guidelines_Anxiety_revision.pdf&amp;token=It3400T0qp+tp17lSjGJ+vB3NWha2HBPGKaNRzlWrl2d3Wx07IVUUFl5rio3ZixUtCG34GczWpbnZeql7clcenJwPdG4Y4FwAKGxaGd5pe28BF5mXDlcgCl/CcAO4rBB&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">WFSBP: Guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders &ndash; First revision</a> (2008)</p><p/><p class=\"headingAnchor\" id=\"H279686091\"><span class=\"h1\">Canada</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://bmcpsychiatry.biomedcentral.com/track/pdf/10.1186/1471-244X-14-S1-S1?site=bmcpsychiatry.biomedcentral.com&amp;token=tICMxaEhPpf3RJCjMcM1Gz+p4p923+9WBTiWmDslUXSDbpSbaKF47w2b4pOUvcD6/7+7fiFfLsMk1Vy8SaEL4ml91hUqEQp/EczFwX5g1yjF5O2DhhlhX3tOy+abnEZm&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">Anxiety Disorders Association of Canada (ADAC): Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders</a> (2014)</p><p/><p class=\"headingAnchor\" id=\"H661286391\"><span class=\"h1\">United States</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/neurosurgery/article/75/4/327/2447668/Deep-Brain-Stimulation-for-Obsessive-Compulsive&amp;token=4SCiBslhfHSZzu/JrS3BGwRa4Zlaz8mFtvcKNFQuJRMNKk9dYJqF1twuB3y4VcJZgAGubcLwbf1t0nZeNrLfqFx+dNZmvWjoQt5V7ERs5xEyG5tMqvAfwip3UAEMJo/55L+rTB9JwY2uVP9lhtRDiQ==&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">American Society for Stereotactic and Functional Neurosurgery (ASSFN) and the Congress of Neurological Surgeons (CNS): Systematic review and evidence-based guideline on deep brain stimulation for obsessive-compulsive disorder</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.jaacap.com/article/S0890-8567(11)00882-3/pdf&amp;token=feNRcQLGxc4nRRCD0iVh635jC5X4vIvmCQ0nWNQECc5c346GL5Cvo69mlApVB6eyBZXf/frLFvskgB+oBHnA+g==&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">American Academy of Child and Adolescent Psychiatry (AACAP): Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/ocd.pdf&amp;token=ZlVPMxTEm4CTtDWUDA/XdOzpr5Yxp6BbCpRzsb4mPjQYrCQeuzDjdAC9aJPRnQfUv98fOA0WVzTnkJKpvmjUZsr94LQIruRyWFWa8Ps2H/c=&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">American Psychiatric Association (APA): Practice guideline for the treatment of patients with obsessive-compulsive disorder</a> (2007)</p><p/><p class=\"headingAnchor\" id=\"H3437689414\"><span class=\"h1\">Europe</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003512.pdf&amp;token=kq9ex+P4hUAZAba3S9PiPKAQPBge/+jtAOoCs2JKCLhYj/4/9QXLjnJbBrJZJODxVgSFaZHAeZhnVaoOviTrWCj/JXQ09wnAzSr3aJ0Mmc4Jf2Zu0zBdLESY71cwf5kQ&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">The European Medicines Agency (EMA): Guideline on clinical investigation of medicinal products for the treatment of obsessive compulsive disorder</a> (2005)</p><p/><p class=\"headingAnchor\" id=\"H1390772735\"><span class=\"h1\">United Kingdom</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.bap.org.uk/pdfs/BAP_Guidelines-Anxiety.pdf&amp;token=h7Ird6MEQJ0ciS3wlIS74x1BVgW4EU2ibrMeAhfZCP3H9zkLe+Dbg5hEgIwBhWRLPSuLIGNf7itOhloz1HpD7w==&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">British Association for Psychopharmacology (BAP): Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder &ndash; A revision of the 2005 guidelines</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg31&amp;token=lblfowwGB6QwC91WNuiIf6SDS220EiNtWYYQS8Gn6dMMps8b2qhMnLXIeqOQTBbs&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">National Institute for Health and Care Excellence (NICE): Clinical guideline on obsessive-compulsive disorder and body dysmorphic disorder &ndash; Treatment</a> (2005)</p><p/><p class=\"headingAnchor\" id=\"H1508864789\"><span class=\"h1\">Australia</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.racgp.org.au/download/Documents/AFP/2013/Sep/201309johnson.pdf&amp;token=gHgfAPQIBJZBPDYSeLaRCl1DjcZbcJPUfSsNC6GBqPa9Ah4ynu9P1Vek2IskBtRFNhmTCyX3aFbzxtYBHT+qEXhs9zL+lrClaOesbnKZLr8=&amp;TOPIC_ID=115511\" target=\"_blank\" class=\"external\">Australian National Health and Medical Research Council (NHMRC): Obsessive-compulsive disorder &ndash; The role of the GP</a> (2013)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 115511 Version 1.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H1964995806\" id=\"outline-link-H1964995806\">Introduction</a></li><li><a href=\"#H2621871683\" id=\"outline-link-H2621871683\">International</a></li><li><a href=\"#H279686091\" id=\"outline-link-H279686091\">Canada</a></li><li><a href=\"#H661286391\" id=\"outline-link-H661286391\">United States</a></li><li><a href=\"#H3437689414\" id=\"outline-link-H3437689414\">Europe</a></li><li><a href=\"#H1390772735\" id=\"outline-link-H1390772735\">United Kingdom</a></li><li><a href=\"#H1508864789\" id=\"outline-link-H1508864789\">Australia</a></li></ul></div>","javascript":null}